Ph 3 readouts in Q1 2024...

$Pfizer(PFE.US)$ Phase 3
$Regenxbio(RGNX.US)$ Phase 3
$Annovis Bio(ANVS.US)$ Phase 3
$Atea Pharmaceuticals(AVIR.US)$ Phase 3
$Ironwood Pharmaceuticals(IRWD.US)$ Phase 3
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 3
$Vertex Pharmaceuticals(VRTX.US)$ Phase 3
$KalVista Pharmaceuticals(KALV.US)$ Phase 3
$Axsome Therapeutics(AXSM.US)$ Phase 3
$Novocure(NVCR.US)$ Phase 3
$ROCHE HOLDING AG(RHHBY.US)$ Phase 3
$FibroGen(FGEN.US)$ Phase 3
$Applied Therapeutics(APLT.US)$ Phase 3
$ACADIA Pharmaceuticals(ACAD.US)$ Phase 3
$Sellas Life Sciences(SLS.US)$ Phase 3
$G1 Therapeutics(GTHX.US)$ Phase 3
$Crinetics(CRNX.US)$ Phase 3
$Aquestive Therapeutics(AQST.US)$ Phase 3
$Intra-Cellular Therapies(ITCI.US)$ Phase 3
$Jaguar Health(JAGX.US)$ Phase 3
$Johnson & Johnson(JNJ.US)$ Phase 3